1
项与 Dengue (Asterivir) 相关的临床试验Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Investigate the Efficacy, Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TDV) Administered Subcutaneously in Healthy Children Aged 4 – 16 Years Old
100 项与 Dengue (Asterivir) 相关的临床结果
100 项与 Dengue (Asterivir) 相关的转化医学
100 项与 Dengue (Asterivir) 相关的专利(医药)
100 项与 Dengue (Asterivir) 相关的药物交易